FeesSafety
Pluang+

Moleculin completes treatment in AML trial, data readout expected Q1 2027, advancing Annamycin development.

Company Fundamentals
16 Nov 2026, 14:30 WIB
GlobeNewsWire
View Source
Bullish
Moleculin completes treatment in AML trial, data readout expected Q1 2027, advancing Annamycin development.

Moleculin Biotech completed treatment of all 90 patients in Part A of its pivotal Phase 2/3 MIRACLE trial for relapsed or refractory acute myeloid leukemia (AML). The company expects a comprehensive data readout in Q1 2027, which will guide optimal dosing and the start of Part B in H1 2027. Annamycin shows a strong cardiac safety profile and potential to enhance immune response in pancreatic cancer. Financially, Moleculin reported a $6.5 million net loss for Q3 2026, with ongoing R&D investments supporting clinical progress.

Moleculin Biotech's Q3 2026 financial results and clinical trial progress provide context for readers. For those tracking health-sector stocks, 67 of 150 rose and 61 fell today on Pluang. Notable movers include HIMS at USD 19.01 with a -3.65% change, CNC at USD 73.80 up 3.55%, and BKD at USD 8.85 down 3.49%, as of Nov 16, 2026 19:13 WIB.

More News

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike is under pressure to clarify its cost-cutting plans as it prepares for its first investor day since 2017, scheduled for November 16–17. Despite efforts led by CEO Elliott Hill to turn the company around, management expects revenue to decline by ...

Market News
Bearish
55 minutes ago
Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric have partnered to create North America's first plug-and-play virtual power plant (VPP) for renters and apartment residents, starting in New York City. This innovative system uses portable power stations plugged into standar...

Market News
Bullish
1 hour ago
P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI has appointed retired Brigadier General Matt Isler as General Manager for its Aerospace and Defense division. Isler brings nearly 30 years of military and industry experience, including leadership roles at Northrop Grumman and startup DEFCON A...

Market News
Bullish
1 hour ago
Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo Inc. has renewed its Normal Course Issuer Bid (NCIB), allowing it to repurchase up to 22.5 million common shares, representing 10% of its public float, from November 19, 2026, to November 18, 2027. This move reflects Saputo's strategy to retur...

Company Fundamentals
Bullish
2 hours ago
GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian has launched the Enterprise Good Samaritan Program to identify and notify companies about high-impact leaked credentials that could expose their systems to attackers. Using AI and expert analysis, the program traces leaks to affected orga...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App